|
|
||||||||
Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland; and Department of Pathology, George Washington University Medical Center, Washington, DC
Correspondence: Sharon M. Wahl, PhD, NIDCR, NIH, 30 Convent Drive, MSC 4352, Building 30, Room 332, Bethesda, MD 20892-4352. E-mail: smwahl{at}dir.nidcr.nih.gov
Immunodeficiency, the consequence of HIV-1 infection, predisposes
the host to opportunistic infections. In turn, opportunistic pathogens
influence target cell susceptibility to HIV-1 infection and
replication. Although the advent of highly active antiretroviral
therapy (HAART) has altered these sequelae, co-infections may prevail
in some parts of the world and in failed HAART regimens. Moreover,
immune activation as occurs in tonsil and non-infectious mucosal
inflammatory lesions may also be associated with proximal sites of
viral replication. These connections between enhancement of HIV-1
infection and activation/inflammation warrant further elucidation of
the factors promoting permissiveness to HIV-1 infection. Using the
opportunistic pathogen Mycobacterium avium as an in
vitro model, we demonstrated that co-infection facilitated HIV-1
infection of monocyte-macrophages by multiple pathways. M.
avium activated NF-
B, the downstream consequences of which
included augmented expression of tumor necrosis factor
and CCR5
receptors, both permissive for sustaining HIV-1 infection. Pronounced
viral replication in lymph nodes co-infected with M. avium
and HIV-1 paralleled these in vitro findings. Furthermore,
reduction in viral burden is associated with treatment of infected or
inflamed tissues, underscoring the link between immune activation and
viral replication.
Key Words: Mycobacterium avium nuclear factor
ß viral replication
This article has been cited by other articles:
![]() |
S. M. Wahl, T. Greenwell-Wild, and N. Vazquez HIV accomplices and adversaries in macrophage infection J. Leukoc. Biol., November 1, 2006; 80(5): 973 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Moutsopoulos, N. Vazquez, T. Greenwell-Wild, I. Ecevit, J. Horn, J. Orenstein, and S. M. Wahl Regulation of the tonsil cytokine milieu favors HIV susceptibility J. Leukoc. Biol., November 1, 2006; 80(5): 1145 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Darnell, W. A. Schroder, J. Gardner, D. Harrich, H. Yu, R. L. Medcalf, D. Warrilow, T. M. Antalis, S. Sonza, and A. Suhrbier SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication J. Biol. Chem., October 20, 2006; 281(42): 31348 - 31358. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.M. Moutsopoulos, T. Greenwell-Wild, and S.M. Wahl Differential Mucosal Susceptibility in HIV-1 Transmission and Infection Adv. Dent. Res., April 1, 2006; 19(1): 52 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Israel-Biet, H Esvant, A M Laval, and J Cadranel Impairment of {beta} chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia Thorax, March 1, 2004; 59(3): 247 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ghassemi, R. M. Novak, M. F. Khalili, and J. Zhou Viable Mycobacterium avium is required for the majority of human immunodeficiency virus-induced upregulation in monocytoid cells J. Med. Microbiol., October 1, 2003; 52(10): 877 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Greenwell-Wild, N. Vazquez, D. Sim, M. Schito, D. Chatterjee, J. M. Orenstein, and S. M. Wahl Mycobacterium avium Infection and Modulation of Human Macrophage Gene Expression J. Immunol., December 1, 2002; 169(11): 6286 - 6297. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hale-Donze, T. Greenwell-Wild, D. Mizel, T. M. Doherty, D. Chatterjee, J. M. Orenstein, and S. M. Wahl Mycobacterium avium Complex Promotes Recruitment of Monocyte Hosts for HIV-1 and Bacteria J. Immunol., October 1, 2002; 169(7): 3854 - 3862. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. T. Keppler, F. J. Welte, T. A. Ngo, P. S. Chin, K. S. Patton, C.-L. Tsou, N. W. Abbey, M. E. Sharkey, R. M. Grant, Y. You, et al. Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1 J. Exp. Med., March 18, 2002; 195(6): 719 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Montaner, C.-F. Perno, and S. Crowe Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis J. Leukoc. Biol., September 1, 2000; 68(3): 301 - 302. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |